This country profile provides an overview of Angola’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
2.31 million people received treatment in Angola in 2019 13.05 million people did not receive treatment in Angola in 2019
Treatment coverage increased from 1% in 2018 to 11% in 2019.
People needing treatment2.39m
People receiving treatment264k
Angola does not require mass treatment for blinding trachoma.
Treatment coverage decreased from 25% in 2018 to 14% in 2019.
Pre sch and school-aged children needing treatment12.19m
Pre sch and school-aged children receiving treatment1.73m
Treatment coverage decreased from 51% in 2018 to 27% in 2019.
School-aged children needing treatment4.07m
School-aged children receiving treatment1.12m
Treatment coverage decreased from 20% in 2018 to 12% in 2019.
People needing treatment5.76m
People receiving treatment670k
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Angola.